Extended territorial (scope 1 and 2) per capita CO₂ emissions and per capita CFs across 354 municipalities in England by Jan Minx (557244)

“…</strong> Extended territorial (scope 1 and 2) per capita CO₂ emissions and per capita CFs across 354 municipalities in England. …”

Supplementary Material for: Effect of Honey-lime spray as add-on therapy on chemotherapy-induced xerostomia in breast cancer patients: A pilot randomized double-blinded controlled... by Heydarirad G. (17839823)

“…Results: The standardized value of the difference between the mean scores before and after the study was -10.21 (P<0.001), and the effect size was estimated at 55%. Also, VAS showed a significant decrease in pain for the intervention group compared with the control group (P<0.001). …”

Morphometric comparison between experimental and synthetic microcirculatory networks from the murine vibrissa primary sensory cortex. by Grant Hartung (5987810)

Table_1_A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™).docx by Fethi Gül (12282977)

“…During the 5 days of treatment, there was a sustainable and gradual improvement on oxygenation parameters: i.e. respiratory rate (RR) [20.8% (P < 0.05)], oxygen saturation (SpO₂) [6,7% (P < 0.05)] and partial pressure of oxygen to the fraction of inspired oxygen (PaO₂/FiO₂) [127.9% (P < 0.05)] that correlated with steep decrease in the disease activity scores and inflammatory markers, i.e. the sequential organ failure assessment (SOFA) score (75%, p < 0.05), C-reactive protein (46% p < 0.05), ferritin (58% p = 0.53), D-dimer (28% p=0.46). …”

Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx by Jae-Sung Lim (532986)

“…Given the limited number of patients and potential residual confounding, our results should be considered hypothesis-generating and need replication in larger cohorts in the future.</p>…”

Data Sheet 1_Trends in nontraumatic subarachnoid hemorrhage-related mortality among young adult (15–64 years) population in the United States, 1999–2022.docx by Olivia Foley (20535083)

DataSheet_1_Predicting pathological complete response after neoadjuvant chemotherapy: A nomogram combining clinical features and ultrasound semantics in patients with invasive brea... by Ke-Nie Wang (13790545)

DataSheet1_Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression.PDF by Fu Peng (1426402)

Data_Sheet_1_Certain Environmental Conditions Maximize Ammonium Accumulation and Minimize Nitrogen Loss During Nitrate Reduction Process by Pseudomonas putida Y-9.PDF by Xuejiao Huang (6401246)

The fPCs, their gene specific scores, and the discriminating boundary explain changing collective phasing in double mutants. by Leo Zeitler (13775500)

“…The two clusters are given in orange and blue, and the SVM boundary is depicted by the black dashed line. Whilst <i>isw2</i>Δ<i>chd1</i>Δ and <i>isw1</i>Δ<i>isw2</i>Δ require both fPCs to linearly separate the Pearson clusters, <i>rsc8chd1</i>Δ is almost exclusively dependent on the second fPC, which means this mutant decreased the slope tilt. …”

<b>Adiponectin Receptor Agonist AdipoRon Ameliorates the Metabolic Complications in a Hyperandrogenic Rat Model of Polycystic Ovary Syndrome (PCOS) - Raw Datasets</b> by Ahmed M. Abdelhameed (16411192)

“…AdipoRon also reduced mitochondrial oxidative stress in both WAT depots and decreased AR expression in VAT.</p><p dir="ltr">AdipoRon attenuates hyperandrogenemia-induced adiposity and IR in a PCOS model by improving adipose insulin and adiponectin signaling, reducing mitochondrial oxidative stress and food intake, supporting its therapeutic potential in managing IR and obesity in PCOS women.…”

Table_1_Dosimetric Evaluation of Commercially Available Flat vs. Self-Produced 3D-Conformal Silicone Boluses for the Head and Neck Region.xlsx by Stephan Pollmann (2821559)

“…Dose measurements for both types of boluses were performed with radiochromic films (EBT3) at three points per patient—at least one aimed to be in the high-dose area (scar) and one in the lower-dose area (spared healthy skin). …”

Data_Sheet_1_Movement patterns in tuba playing: comparison of an embouchure dystonia case with healthy professional tuba players using real-time MRI imaging.PDF by Robert Nelkenstock (15442817)

“…Concerning different playing techniques, it was apparent, that notes played slurred or staccato resulted in a larger oral cavity when compared to notes played tongued or tenuto, respectively.…”

Image_6_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_4_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_2_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_7_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_3_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_5_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”

Image_1_Enteral Lactoferrin Supplementation for Preventing Sepsis and Necrotizing Enterocolitis in Preterm Infants: A Meta‑Analysis With Trial Sequential Analysis of Randomized Con... by Ya Gao (526722)

“…</p>Conclusions<p>Limited evidence suggested that enteral lactoferrin supplementation was associated with a reduction of late-onset sepsis in infants with a birth weight below 1500g, however, did not decrease the incidence of NEC stage II or III, all-cause mortality, and other adverse events in preterm infants. …”